Adopted on 18/05/2022 - Bureau decision date: 18/01/2022Reference: SOC/716-EESC-2022Opinion Type: MandatoryReferral: COM(2022) 18 final 2022/0009 CODCOM(2022) 18 final 2022/0009 COD Rapporteur: Milena ANGELOVA (Employers - GR I / Bulgaria) Co-rapporteur: Małgorzata Anna BOGUSZ (Diversity Europe - GR III/Poland) Plenary session: 569 - May 18, 2022 May 19, 2022 Health EESC opinion: European Union Drugs Agency bg es cs da de et el en fr ga hr it lv lt hu mt nl pl pt ro sk sl fi sv